Minireviews
Copyright ©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 95987
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95987
Table 1 Possible proposal of acceptable liver donors with history of or current genitourinary malignancy (adapted from[15])
Minimal risk
Low to intermediate risk
High risk
Unacceptable risk
Current
NMIBC – in situ and T1Prostate cancer-Gleason score 7Prostate cancer- Gleason score >7Metastatic prostate cancer
Prostate cancer - Gleason score ≤ 6RCC 1-4 cm and Fuhrman grade I/II RCC > 7 cm and Fuhrman grade III/IVRCC stages T3/T4
RCC < 1 cm and Fuhrman grade I/IIRCC 4-7 cm and Fuhrman grade I/II MIBC – post chemoradiation
History
Prostate cancer Gleason up to 6 Prostate cancer Gleason = 7 after curative treatment and cancer-free period > 5 yrRCC 1-4 cm, FG I/II; RCC 4-7 cm, FG I/IIProstate cancer with extraprostatic spreadAny metastatic genitourinary malignancy
RCC < 1 cm and FG I/IIRCC > 7 cm and FG III/IVRCC stages T3/T4
Table 2 Possible proposal of waiting time until liver transplantation for recipients with a history of genitourinary malignancy (adapted from[29])
Cancer
Tumor stage and/or grade
Time interval to transplant
Prostate Up to T3 stage and regardless of Gleason scoreNo wait time
Metastatic castration-sensitive prostatic cancerStable disease for 2 yr with prolonged estimated life expectancy – 2 yr
Metastatic castration-resistantNot a LT candidate
Renal cell carcinomaT1a (≤ 4 cm) and T1b (4-7 cm) with N0, M0 and Fuhrman grade I/IINo wait time
T1b, N0, M0 and FG III/IV and T2N0M02 yr
T3 and T4 – both N0M0Minimum 2 yr then reassess
Any T, N+, M+ Not a LT candidate
Bladder NMIBC (solitary tumor, low grade, absence of carcinoma in situ (CIS), high grade tumor < 3 cm)6 mo
NMIBC (any CIS, high-grade tumor > 3 cm, high grade T1 tumor, any recurrent high-grade Ta tumor, lymphovascular invasion)2 yr
MIBC, postradical cystectomy2 yr
MIBC, post chemoradiationNot a LT candidate